SCHEMBL13409057

SCHEMBL13409057

c1ccc2c(c1)Cc1ccccc1N2c1ccc(-c2cc3cc(-c4ccc5ccccc5c4)c4ccccc4c3c3ccccc23)cc1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSTP1 P09211 1/20 0.36
HPGD P15428 2/20 0.35
ALDH1A1 P00352 1/20 0.34
LMNA P02545 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP2C9 P11712 1/20 0.34
CYP2C19 P33261 1/20 0.34
GPR84 Q9NQS5 1/20 0.34
MET P08581 1/20 0.34
PDE6D O43924 1/20 0.33
HTR3A P46098 1/20 0.32
CSNK1D P48730 4/20 0.32
MAPK11 Q15759 4/20 0.32
MAPK14 Q16539 4/20 0.32
HDAC4 P56524 1/20 0.31
HDAC2 Q92769 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
PRKDC P78527 1/20 0.31
CNR2 P34972 1/20 0.31
AKT1 P31749 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13408792 0.92 HPGD (0.41) HPGDALDH1A1PDE6DEGFR
SCHEMBL13409043 0.90 HPGD (0.42) HPGDALDH1A1GPR84PDE6DEGFR
SCHEMBL13409037 0.86 PDE6D (0.38) HPGDALDH1A1PDE6DHDAC8PRKDC
SCHEMBL13408722 0.85 HPGD (0.43) HPGDALDH1A1PDE6DEGFR
SCHEMBL13408797 0.84 PDE6D (0.35) HPGDALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13340268 0.83 PDE6D (0.34) GSTP1HPGDALDH1A1LMNACYP1A2
SCHEMBL13409054 0.82 GPR84 (0.36) GSTP1HPGDALDH1A1GPR84PDE6D
SCHEMBL13409080 0.82 PDE6D (0.39) HPGDALDH1A1LMNACYP1A2CYP2C9
SCHEMBL13408881 0.81 GSTP1 (0.36) GSTP1HPGDALDH1A1LMNACYP1A2
SCHEMBL13409073 0.81 KMT2A (0.34) GSTP1HPGDALDH1A1LMNACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 US disclosed
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same GRACEL DISPLAY INC. (KR) 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100096982-A1 Novel organic electroluminescent compounds and organic electrouminescent device using the same OCIAD1, OR10J3, ORMDL3 GSTP1 1996/4885HPGD 785/4885ALDH1A1 208/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.